Beulah Moody, former director of education at Easterseals Western and Central Pennsylvania, recently celebrated her 100th birthday as well as a 19-year career of benefitting children who have disabilities through Easterseals.

Scientists recently received funds from the National Institutes of Health (NIH) to monitor the coaches, athletes and staff of the U.S. Olympic Committee at the 2016 Summer Olympics and Paralympics in Brazil, as they have higher chances of contracting the Zika virus while abroad.

The Republican health care plan unveiled last month by U.S. House Speaker Paul Ryan isn’t a perfect free-market system, but it’s a realistic, positive alternative to the Affordable Care Act (ACA), Hadley Heath Manning, senior policy analyst and director of health policy at the Independent Women's Forum (IWF), said

Leaders with the American Cancer Society Cancer Action Network (ACS CAN) recently started a new ad campaign that encourages the public and Congress to focus on prioritizing federal funding dedicated to cancer research.

Leaders with the U.S. Health and Human Services (HHS) recently announced their new approach to fighting the opioid epidemic within the United States.

The House of Representatives recently passed H.R. 5210, or the PADME Act, which is a bipartisan legislation containing two committee provisions for improving Medicaid and Medicare.

Rep. Michael Burgess (R-TX) recently planned a hearing for members of the Subcommittee on Commerce, Manufacturing and Trade (SubCMT) to evaluate mobile health apps.

The Partnership for Research on Ebola Virus in Liberia (PREVAIL) IV treatment trial recently launched in Liberia, testing a treatment for men who survived Ebola but still have the genetic material (RNA) of the virus in their semen.

Eli Lilly and Company recently gathered its leaders at the National Mayor’s Conference to discuss how Alzheimer’s disease affects local communities throughout the U.S.

The latest data from a study show that Jardiance (empagliflozin) significantly decreases the chance of progressive kidney disease among adults who have both type 2 diabetes and cardiovascular disease.

Members of the Healthcare Leadership Council, a group of chief executives from top health care companies across the U.S., recently announced that the council supports legislation to change the Congressional Budget Office (CBO).

Officials with the Centers for Medicare and Medicaid Services (CMS) recently proposed an increase for hospital outpatient prospective payment systems of approximately 1.55 percent during the 2017 calendar year compared to 2016.

U.S. House and Senate leaders involved in opioid conferees have scheduled a meeting to discuss the legislative text for the S. 524 conference report, titled the Comprehensive Addiction and Recovery Act of 2016.

Officials with the American Cancer Society, which is the biggest private, not-for-profit funder of cancer research, recently announced that they intend to double the organization’s yearly research funding by the year 2021.

The American Health Association (AHA) recently announced a new partnership with Amazon Web Services Inc. (AWS), a top cloud computing infrastructure, to improve cardiovascular medicine and science through cloud technology.

A new bipartisan bill, called the Independence at Home Act of 2016, could be the answer to lower costs and better quality for patients on Medicare.

Leaders at the U.S. Food and Drug Administration (FDA) have moved forward with the President’s Medicine Initiative by completing two draft guidances to offer streamlined, flexible methods for overseeing genomic medical tests.

House Speaker Paul Ryan recently laid out a health care plan that would serve as a Republican alternative to Obamacare, leaving some of the health care law’s current provisions in place and replacing the less popular ones.

The National Health Council (NHC) board of directors recently elected two new members during its meeting on June 14, effectively replacing its two retiring board members.

A subcommittee in the U.S. House recently approved of a new appropriations bill that would increase the funding dedicated to Alzheimer’s disease research by approximately $350 million.